2019
DOI: 10.1016/j.freeradbiomed.2018.10.445
|View full text |Cite
|
Sign up to set email alerts
|

GCN2 deficiency ameliorates cardiac dysfunction in diabetic mice by reducing lipotoxicity and oxidative stress

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
36
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 38 publications
(39 citation statements)
references
References 57 publications
3
36
0
Order By: Relevance
“…Previous reports have shown that oxidative stress may be cell toxic for cardiac myocytes . DCFH‐DA fluorescence probe was performed to measure ROS of different groups in vitro.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Previous reports have shown that oxidative stress may be cell toxic for cardiac myocytes . DCFH‐DA fluorescence probe was performed to measure ROS of different groups in vitro.…”
Section: Resultsmentioning
confidence: 99%
“…Under some conditions, LKB1 is phosphorylated at Ser428 (pLKB1) and then translocated to the cytosol and subsequently induces activation of AMPK . Although several lines of evidence demonstrate that AMPK phosphorylation is attenuated in diet‐induced obesity (DIO) mouse hearts, the mechanisms by which AMPK phosphorylation is decreased are not fully elucidated.…”
Section: Introductionmentioning
confidence: 99%
“…Inflammation and oxidative stress have been reported to markedly affect the development and progression of diabetes, as well as its complications (8,9). Additionally, previous studies have indicated that uncontrolled inflammation and oxidative stress may contribute to cardiac dysfunction in diabetic cardiac tissues (10,11). Extensive research has also revealed that mitochondrial injury may serve as a central mediator in the pathology of DCM (12,13).…”
Section: Introductionmentioning
confidence: 99%
“…Interestingly, loss of GCN2 function resulted in increased expression of the anti-apoptotic factor Bcl-2, along with a reduction in both oxidative stress and cardiomyocyte cell death via apoptosis [53]. Another study conducted on diabetic GCN2 −/− mice demonstrated reduction in lipotoxicity and oxidative stress [54]. Together, these studies provide an explanation for the cardioprotective role of GCN2 deletion.…”
Section: Translation Initiation Factor Eif2mentioning
confidence: 90%
“…On the contrary, in vivo treatment of male C57Bl/6J mice and human cardiac fibroblasts with halofuginone, a bioactive compound that induces the GCN2-mediated stress response pathway, also resulted in improved survival, ventricular function, and reduced ischemic injury in mice [55]. These contradictory findings most likely stem from the fact that different experimental systems were used [53][54][55]. It is also possible that, in addition to activating the GCN2-stress response pathway, halofuginone may have off-target effects; thus, these data cannot be directly compared to the effects of a permanent deletion of GCN2 on the cardiac system.…”
Section: Translation Initiation Factor Eif2mentioning
confidence: 99%